Seethala Raja R, Hunt Jennifer L, Baloch Zubair W, Livolsi Virginia A, Leon Barnes E
Department of Pathology and Laboratory Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Am J Surg Pathol. 2007 Nov;31(11):1683-94. doi: 10.1097/PAS.0b013e3180dc928c.
High-grade transformation of adenoid cystic carcinoma (ACC) (previously referred to as dedifferentiation) is a rare phenomenon that does not fit into the traditional ACC grading schemes. The importance and minimal criteria for distinction from solid (grade III) ACC are not well established. We report 11 new cases and review the literature to further define the profile of this tumor. The median age was 61 years (range: 32 to 72 y) with a male predominance (male to female ratio of 1.75:1). The most commonly involved sites were sinonasal (4/11) and submandibular (4/11). Lymph nodes were pathologically positive in 4/7 (57.1%) cases. Distant metastases to the lung (n=2) and soft tissue of the shoulder (n=1) were observed. Five of 9 patients (55.6%) died, all within 5 years with a median overall survival of 12 months. Histologically, ACC with high-grade transformation was distinguished from conventional ACC by nuclear enlargement and irregularity, higher mitotic counts, and the loss of the biphasic ductal-myoepithelial differentiation. Useful supportive criteria were prominent comedonecrosis and fibrocellular desmoplasia. The most common morphologies for the high-grade component were poorly differentiated cribriform adenocarcinoma and solid undifferentiated carcinoma. Micropapillary and squamoid patterns were occasionally present. Ki-67 and p53 labeling indices were elevated in the high-grade components, though c-kit and cyclin-D1 were not. ACC-high-grade transformation is a highly aggressive salivary gland tumor with a variety of histologic patterns. The high propensity for lymph node metastases suggests a role for neck dissection in patients with this rare tumor.
腺样囊性癌(ACC)的高级别转化(以前称为去分化)是一种罕见现象,不符合传统的ACC分级方案。与实性(III级)ACC鉴别的重要性和最低标准尚未明确确立。我们报告11例新病例并回顾文献,以进一步明确这种肿瘤的特征。中位年龄为61岁(范围:32至72岁),男性占优势(男女比例为1.75:1)。最常累及的部位是鼻窦(4/11)和下颌下腺(4/11)。7例中有4例(57.1%)病理检查显示淋巴结阳性。观察到有2例发生肺远处转移,1例发生肩部软组织远处转移。9例患者中有5例(55.6%)死亡,均在5年内,中位总生存期为12个月。组织学上,高级别转化的ACC与传统ACC的区别在于细胞核增大和形态不规则、有丝分裂计数更高,以及双相导管-肌上皮分化消失。有用的支持标准是显著的粉刺样坏死和纤维细胞性促结缔组织增生。高级别成分最常见的形态是低分化筛状腺癌和实性未分化癌。偶尔可见微乳头和鳞状模式。高级别成分中Ki-67和p53标记指数升高,而c-kit和细胞周期蛋白D1则未升高。ACC高级别转化是一种具有多种组织学模式的高度侵袭性涎腺肿瘤。淋巴结转移的高倾向表明对于患有这种罕见肿瘤的患者,颈部清扫术可能有用。